Cancer News and Research

Latest Cancer News and Research

Taller individuals are less likely to develop esophageal cancer

Taller individuals are less likely to develop esophageal cancer and it's precursor, Barrett's esophagus, according to a new study1 in Clinical Gastroenterology and Hepatology, the official clinical practice journal of the American Gastroenterological Association.

26 Sep 2014

New approach to create treatments for osteoporosis, autoimmune diseases

Scientists have developed an approach to creating treatments for osteoporosis and autoimmune diseases that may avoid the risk of infection and cancer posed by some current medications.

26 Sep 2014

Study on widespread vitamin D deficiency among patients who undergo thyroidectomy

A new study from researchers at Henry Ford Hospital in Detroit finds widespread vitamin D deficiency among patients who undergo a thyroidectomy, potentially putting them at greater risk for developing dangerously low blood calcium levels after surgery.

26 Sep 2014

Helsinn to present Phase III trial data of anamorelin at ESMO Congress

Helsinn Group, a company focused on building quality cancer care, today announces that Phase III data from the largest trial program of its kind to date in anamorelin, a novel, once-daily ghrelin receptor agonist in development for cancer-anorexia-cachexia (CACS) in non-small cell lung cancer will be presented at the 38th European Society for Medical Oncology Congress in Madrid, Spain, in 2014.

25 Sep 2014

Colorado cancer researchers launch feasibility study to build nation's first carbon-ion radiotherapy facility

Colorado cancer researchers and medical doctors on Wednesday announced they are launching a $200,000 feasibility study as a key step to building the nation's first carbon-ion radiotherapy research and treatment facility in Aurora, where they and colleagues hope to investigate and provide to patients leading-edge radiation therapy that is effective against the deadliest cancers and now is available only in Europe and Japan.

25 Sep 2014

NCCN ORP awards four research grants to advance development of nintedanib

The National Comprehensive Cancer Network Oncology Research Program has awarded four grants to investigators to evaluate and define the clinical effectiveness of the investigational compound nintedanib (BIBF 1120) in non-small cell lung, colorectal, and gastrointestinal cancers.

25 Sep 2014

New CRUK-MEDI Alliance Laboratory to focus on development of novel biologic cancer treatments

CANCER RESEARCH UK, with its commercial arm Cancer Research Technology, today announce that they have entered into an innovative collaboration with AstraZeneca and MedImmune, its global biologics research and development arm, to establish a joint laboratory in Cambridge, UK.

25 Sep 2014

Elsevier honored at BMA Medical Book Awards ceremony

Elsevier, a world-leading provider of scientific, technical and medical information products and services, announced today that 28 of its professional and scholarly products were honored at the British Medical Association's annual BMA Medical Book Awards ceremony at BMA House in London on Sept. 22, 2014.

25 Sep 2014

Pitt researchers awarded new $5.8 million NIH grant to develop microfluidic 3D liver model system

With a new $5.8 million, three-year award from the National Institutes of Health, researchers at the University of Pittsburgh School of Medicine will further develop a state-of-the-art, microfluidic 3D model system that mimics structure and function of the liver to better predict organ physiology, assess drug toxicity and build disease models.

25 Sep 2014

Research findings open up new avenues for development of chronic itch treatments

Areas of the brain that respond to reward and pleasure are linked to the ability of a drug known as butorphanol to relieve itch, according to new research led by Gil Yosipovitch, MD, Professor and Chairman of the Department of Dermatology at Temple University School of Medicine, and Director of the Temple Itch Center.

25 Sep 2014

Ohio State researchers develop novel anticancer peptide vaccines and inhibitors

Researchers have developed two new anticancer peptide vaccines and two peptide inhibitors as part of a larger peptide immunotherapy effort at The Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J. Solove Research Institute.

25 Sep 2014

Researchers reveal why RB1 gene mutations primarily cause retinoblastomas in children

Retinoblastoma is a childhood retinal tumor usually affecting children one to two years of age. Although rare, it is the most common malignant tumor of the eye in children.

25 Sep 2014

TSRI scientists awarded DARPA grant to build artificial immune system

Scientists from both campuses of The Scripps Research Institute have been awarded a total of $7.9 million from the Defense Advanced Research Projects Agency of the U.S. Department of Defense.

25 Sep 2014

Study identifies potential way to improve treatment for chemo-resistant ovarian cancer

Ovarian cancer is the most deadly gynecological cancer, claiming the lives of more than 50% of women who are diagnosed with the disease.

25 Sep 2014

Bacterial communication molecules can be manipulated to prevent cancer cells from spreading

Cancer, while always dangerous, truly becomes life-threatening when cancer cells begin to spread to different areas throughout the body.

25 Sep 2014

Anti-addiction activists press for FDA chief to step down

More than a dozen organizations are asking that Dr. Margaret Hamburg, who has headed the Food and Drug Administration since 2009, be replaced because under her leadership they say the agency's policies have contributed to prescription painkiller abuse.

25 Sep 2014

Cancer News and Research

Latest Cancer News and Research

Taller individuals are less likely to develop esophageal cancer

New approach to create treatments for osteoporosis, autoimmune diseases

Study on widespread vitamin D deficiency among patients who undergo thyroidectomy

Helsinn to present Phase III trial data of anamorelin at ESMO Congress

Colorado cancer researchers launch feasibility study to build nation's first carbon-ion radiotherapy facility

NCCN ORP awards four research grants to advance development of nintedanib

New CRUK-MEDI Alliance Laboratory to focus on development of novel biologic cancer treatments

Elsevier honored at BMA Medical Book Awards ceremony

Pitt researchers awarded new $5.8 million NIH grant to develop microfluidic 3D liver model system

Research findings open up new avenues for development of chronic itch treatments

Ohio State researchers develop novel anticancer peptide vaccines and inhibitors

Researchers reveal why RB1 gene mutations primarily cause retinoblastomas in children

TSRI scientists awarded DARPA grant to build artificial immune system

Study identifies potential way to improve treatment for chemo-resistant ovarian cancer

Bacterial communication molecules can be manipulated to prevent cancer cells from spreading

Anti-addiction activists press for FDA chief to step down

Chemotherapy may benefit advanced pulmonary carcinoid tumour patients

Antacids linked to reduced erlotinib efficacy

XAGE1 antibody confers survival benefits to lung adenocarcinoma patients

ACT for NIH seeks significant funding increase to enhance life-saving medical research

Cancer Research - Second Edition eBook

Innovating Texture and Culture in Plant-Based Foods

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Cancer News and Research

Latest Cancer News and Research

Cancer Research - Second Edition eBook

Innovating Texture and Culture in Plant-Based Foods

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Newsletters you may be interested in